SCHEMBL9952977

SCHEMBL9952977

COc1c(CCNc2ncnc3c2ncn3C2CCCCO2)cc(Cl)c(F)c1C1CN(C(=O)O)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
HPGD P15428 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ADORA2A P29274 2/20 0.41
ADORA2B P29275 2/20 0.41
CYP2C19 P33261 1/20 0.38
YTHDC1 Q96MU7 1/20 0.38
TSHR P16473 1/20 0.37
TP53 P04637 1/20 0.36
CYP2C9 P11712 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
APEX1 P27695 1/20 0.36
PI4KA P42356 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9952469 0.85 CYP1A2 (0.51) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9952305 0.85 CYP1A2 (0.52) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9953435 0.83 CYP1A2 (0.51) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9953053 0.82 CYP1A2 (0.51) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9954087 0.80 CYP1A2 (0.50) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9952246 0.80 CYP1A2 (0.51) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9952059 0.78 NPC1 (0.51) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9952460 0.77 NPC1 (0.50) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9929095 0.76 CYP1A2 (0.39) CYP1A2HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9952889 0.75 CYP1A2 (0.45) CYP1A2HPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655374-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS Incyte Corporation (US) 2013-10-30 EP disclosed
WO-2012087881-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2012-06-28 WO disclosed